Głowacki Law Firm

Broker Crossing Networks (BCN)
European Union Electricity Market Glossary

 

 

 

Under the MiFID II Directive investment firms operating internal broker crossing networks (BCNs) have to assess whether these systems qualify as:

 

- multilateral trading facilities (MTFs) or 

 

organised trading facilities (OTFs) or

 

systematic internalisers (SIs).

 

Under the previous iteration of the law - MiFID I - which was in force till 3 January 2018, brokers used the structure of the BCN to have clients interact with their principal liquidity on an over-the-counter basis and there was no requirement to become an SI or an MTF or an OTF.

 

Given the above MiFID I legal setup and and significant flexibility in the rules on crossing, many large European brokers adopted the BCN framework (ITG, MiFID II: Systematic Internalisers and Liquidity Unbundling, p. 2).

 

The ITG in the above document mentions Goldman Sachs (Sigma/Sigma X) and UBS (PIN/UBS MTF) as examples of firms that chose to operate both a BCN and MTF under MiFID I.

 

In turn, agency-style brokers such as ITG and Instinet, interested only in matching client orders against other client orders, structured their dark pools as MTFs, as for example POSIT MTF and Blockmatch.

 

Firms operating BCNs typically used them to bring together and cross in-house principal ows, client orders and electronic liquidity provider (ELP) ows.

  

MiFID II Directive introduced a fundamental a change to some of these broker structures.

 

Considering. equity OTC trading on a systematic, regular or frequent basis, as was carried out before, is banned under MiFID II, brokers are no longer able to operate BCNs.

 

The options available umder MiFID II are combinations of MTFs, OTFs, SIs or regulated markets.

 

 

 

 

 

 

IMG 0744

    Documentation    

 

 

 

 

 

ITG, MiFID II: Systematic Internalisers and Liquidity Unbundling

 

 

 

 

 

clip2

    Links    

 

 

 

 

 

multilateral system 

 

market operator

 

buying and selling interests 

 

OTC derivatives

 

 

 

 

 

 

 

 

 

 

 

Last Updated on Monday, 17 September 2018 20:47
 

Search

TwitterFacebookLinkedin
Copyright © 2009 - 2018 Michal Glowacki. All rights reserved.
The materials contained on this website are for general information purposes only and are subject to the disclaimer